文献速递乳房整形与再造

自体乳房再造术中及术后抗生素预防使用的证据:一项系统综述

Evidence for the use of peri- and post-operative antibiotic prophylaxis in autologous breast reconstruction: A systematic review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-04-18

本系统综述检索了PubMed、EMBASE、Web of Science和Cochrane Library(2022年1月25日),纳入12项研究,评估自体乳房再造中预防性抗生素方案对手术部位感染的影响。未发现术后持续使用抗生素超过24小时能降低感染率的证据,且无法区分最佳抗菌药物选择。证据质量受限于研究数量少、样本量小、高异质性、未校正混杂因素及定义不统一。

要点

  • 预防性抗生素使用至多24小时有助于降低自体乳房再造的感染率。
  • 未发现术后持续使用抗生素超过24小时能进一步降低感染率的证据。
  • 本综述无法区分最佳抗菌药物选择。

核心结论

  • 预防性抗生素使用至多24小时有助于降低自体乳房再造的感染率。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE、Web of Science和Cochrane Library于2022年1月25日,纳入12项研究。
  • 提取手术部位感染数量、乳房再造类型(带蒂或游离皮瓣)和再造时机(即刻或延迟)以及抗生素类型、剂量、给药途径、时机和疗程数据。
  • 使用修订版RTI Item Bank工具评估纳入文章的潜在偏倚风险。

主要发现

  • 未发现术后持续使用抗生素超过24小时能降低感染率的证据。
  • 本综述无法区分最佳抗菌药物选择。

局限性

  • 证据质量有限,因可用研究数量少(N=12)且研究人群样本量小。
  • 纳入研究具有高异质性、未校正混杂因素且定义互换使用。
  • 强烈建议未来研究采用预设定义并纳入足够数量的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous breast reconstruction has become standard of care, but there is no consensus on prophylactic antibiotic regimens for this surgical procedure. This review aims to present evidence on the best prophylactic antibiotic protocol to lower the risk of surgical site infections in autologous breast reconstructions. METHODS: The search was performed in PubMed, EMBASE, Web of Science, and Cochrane Library on 25th of January 2022. Data on the number of surgical site infections, breast reconstruction type (pedicled or free flap) and reconstruction timing (immediate or delayed), as well as data on the type, dose, route of administration, timing, and duration of antibiotic treatment were extracted. All included articles were additionally assessed for potential risk of bias by using the revised RTI Item Bank tool. RESULTS: 12 studies were included in this review. No evidence is found that giving post-operative antibiotics for a prolonged period longer than 24 h after surgery is useful in lowering infection rates. This review could not distinguish between the best choice of antimicrobial agent. DISCUSSION: Although this is the first study that collected current evidence on this topic, the quality of evidence is limited due to a small number of available studies (N = 12) with small study populations. The included studies have high heterogeneity, no adjustment for confounding, and interchangeably used definitions. Future research is highly recommended with predefined definitions, and a sufficient number of included patients. CONCLUSION: Antibiotic prophylaxis up to a maximum of 24 h is useful in lowering infection rates in autologous breast reconstructions.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Rijkx MEP, Klein DO, Hommes JE, et al. Evidence for the use of peri- and post-operative antibiotic prophylaxis in autologous breast reconstruction: A systematic review. J Plast Reconstr Aesthet Surg. 2023. PMID: 37307619. doi:10.1016/j.bjps.2023.04.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。